515 related articles for article (PubMed ID: 33958439)
1. Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review.
Taha M; Samavati L
RMD Open; 2021 May; 7(2):. PubMed ID: 33958439
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid Antibodies in Critically Ill Patients With COVID-19.
Xiao M; Zhang Y; Zhang S; Qin X; Xia P; Cao W; Jiang W; Chen H; Ding X; Zhao H; Zhang H; Wang C; Zhao J; Sun X; Tian R; Wu W; Wu D; Ma J; Chen Y; Zhang D; Xie J; Yan X; Zhou X; Liu Z; Wang J; Du B; Qin Y; Gao P; Lu M; Hou X; Wu X; Zhu H; Xu Y; Zhang W; Li T; Zhang F; Zhao Y; Li Y; Zhang S
Arthritis Rheumatol; 2020 Dec; 72(12):1998-2004. PubMed ID: 32602200
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
[TBL] [Abstract][Full Text] [Related]
4. Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus.
Akhter E; Shums Z; Norman GL; Binder W; Fang H; Petri M
J Rheumatol; 2013 Mar; 40(3):282-6. PubMed ID: 23378459
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
Foret T; Dufrost V; Salomon Du Mont L; Costa P; Lefevre B; Lacolley P; Regnault V; Zuily S; Wahl D
Curr Rheumatol Rep; 2021 Jul; 23(8):65. PubMed ID: 34218350
[TBL] [Abstract][Full Text] [Related]
6. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
[TBL] [Abstract][Full Text] [Related]
7. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
Borghi MO; Beltagy A; Garrafa E; Curreli D; Cecchini G; Bodio C; Grossi C; Blengino S; Tincani A; Franceschini F; Andreoli L; Lazzaroni MG; Piantoni S; Masneri S; Crisafulli F; Brugnoni D; Muiesan ML; Salvetti M; Parati G; Torresani E; Mahler M; Heilbron F; Pregnolato F; Pengo M; Tedesco F; Pozzi N; Meroni PL
Front Immunol; 2020; 11():584241. PubMed ID: 33178218
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching.
Oba S; Hosoya T; Kaneshige R; Kawata D; Yamaguchi T; Mitsumura T; Shimada S; Shibata S; Tateishi T; Koike R; Tohda S; Hirakawa A; Yoko N; Otomo Y; Nojima J; Miyazaki Y; Yasuda S
Front Immunol; 2023; 14():1227547. PubMed ID: 37908357
[TBL] [Abstract][Full Text] [Related]
9. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.
Sobanski V; Lemaire-Olivier A; Giovannelli J; Dauchet L; Simon M; Lopez B; Yelnik C; Lambert M; Hatron PY; Hachulla E; Dubucquoi S; Launay D
Front Immunol; 2018; 9():2457. PubMed ID: 30464761
[No Abstract] [Full Text] [Related]
11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study.
Najim M; Rahhal A; Khir F; Aljundi AH; Abu Yousef S; Ibrahim F; Amer A; Mohamed AS; Saleh S; Alfaridi D; Mahfouz A; Alyafei S; Howady F; Khatib M; Alemadi SA
Rheumatol Int; 2021 Jul; 41(7):1243-1252. PubMed ID: 33954813
[TBL] [Abstract][Full Text] [Related]
13. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.
Gozzoli GI; Piovani E; Negri B; Mascherpa M; Orabona R; Zanardini C; Zatti S; Piantoni S; Lazzaroni MG; Tomasi C; Prefumo F; Sartori E; Franceschini F; Tincani A; Andreoli L
Front Immunol; 2022; 13():953043. PubMed ID: 36189273
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis.
Merashli M; Alves J; Ames PRJ
Semin Arthritis Rheum; 2017 Apr; 46(5):615-624. PubMed ID: 27838012
[TBL] [Abstract][Full Text] [Related]
15. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
[TBL] [Abstract][Full Text] [Related]
16. Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre.
Barilaro G; Coloma-Bazan E; Chacur A; Della Rocca C; Perez-Isidro A; Ruiz-Ortiz E; Viñas O; Tàssies Penella D; Reverter JC; Molina Andujar A; Cervera R; Espinosa G
Autoimmun Rev; 2022 Dec; 21(12):103208. PubMed ID: 36202304
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
[TBL] [Abstract][Full Text] [Related]
18. Assessment of antiphospholipid antibodies profiles based on severity of COVID-19 pneumonia.
Bnina AB; Dhia RB; Gnaba S; Annabi A; Chouchane S; Naija W; Said H; Oueslati A; Bouatay A
Pan Afr Med J; 2022; 42():110. PubMed ID: 36034019
[TBL] [Abstract][Full Text] [Related]
19. Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study.
Mendel A; Fritzler MJ; St-Pierre Y; Rauch J; Bernatsky S; Vinet É
Res Pract Thromb Haemost; 2023 Jan; 7(1):100041. PubMed ID: 36644653
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
